Hi everyone. A quick background. Age 59. Was diagnosed in Nov 2023 with Gleason 3+4=7 Intermediate Unfavorable (10 of 15 cores positive) and tumor in both side of prostate.
PSA 5.9
Decipher .49
Bone Scan showed no metastasis
Met with Multi Discipline team at Inova Schar Cancer Institute in Fairfax VA on 5 Dec 2023
Inova Schar Cancer Institute
1. RP was primary Recommendation
2. RT Recommendation was 6 mo ADT/EBRT/HDR BT
Scheduled 2nd opinion from Duke Cancer Center Multi Discipline Team for 5 Jan 2024
1. RT was primary recommendation with 6 mo ADT (orgovyx)/SBRT 5 sessions (once per week for 5 weeks)
2. SBRT to prostate only. Not lymph nodes or SV. The RT opinion was the Inova RT recommendation was an overtreatment based on my staging. But, if I wanted to include the Lymph and SV he could do so, but, did not think necessary.
For me RT makes more sense than RP and I want to get best chance of cure while balancing SE. Therefore, I decided that the Duke approach seemed reasonable and have elected to proceed. The ADT is schedule to begin in 10 days, 28 Jan 2024. Thankfully, Insurance picked up cost of Orgovyx with $50 per/mo copay.
Duke did a 2nd opinion on Inova Pathology report from November biopsy (Should have done this earlier from Johns Hopkins). Duke pathology report was almost identical with the exception of downgraded one core from 3+4=7 to 3+3=6. BUT, added Perineural Invasion (PNI) to 1 of the 3+4=7 cores.
I read an article linked by Tall Allen from another post on PNI that said PNI is not always reported by all pathologists, so, perhaps it was simply omitted by the Inova pathologist.
Regardless, I’m not sure whether this report in 1 core alone should change the treatment option and if so what to request. Initial thought would be to simply include lymph nodes and SV in the RT plan. Would love to hear any opinions or someone who had similar circumstances as what treatment was decided upon and outcome.
Thanks for the help.